These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5325787)

  • 21. [The treatment of leprosy and recurrent nodular lepromatous hypodermitis with griseofulvin].
    Silva E
    Dermatol Int; 1968; 7(1):37-42. PubMed ID: 5741762
    [No Abstract]   [Full Text] [Related]  

  • 22. Histoid (high-resistance) lepromatous leprosy.
    Price EW; Fitzherbert M
    Int J Lepr Other Mycobact Dis; 1966; 34(4):367-74. PubMed ID: 6006068
    [No Abstract]   [Full Text] [Related]  

  • 23. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of leprosy by sulfones and delayed-action sulfonamides: comparison of therapeutic results in 100 cases].
    Privat Y; Faye I; Bellossi A
    Mars Med; 1968; 105(3):276-80. PubMed ID: 5754252
    [No Abstract]   [Full Text] [Related]  

  • 25. [Leprosy and lepers in Marseilles].
    Blanc F; Nosny Y
    Bull Soc Pathol Exot Filiales; 1970; 63(4):417-29. PubMed ID: 5537228
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD; Tantiongco PR
    Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sulfonamides and leprous neuritis].
    Carayon A; Languillon J; Daney P
    Bull Soc Med Afr Noire Lang Fr; 1965; 10(4):560-2. PubMed ID: 5865751
    [No Abstract]   [Full Text] [Related]  

  • 28. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-drug treatment for reactions in leprosy.
    Razack EM; Zahra A
    Lepr India; 1981 Apr; 53(2):204-12. PubMed ID: 7253572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of leprosy using sulfamethoxypyrimidine].
    Mattos O; Rabelo Neto AV
    Rev Bras Med; 1970 Jun; 27(6):328-30. PubMed ID: 5488613
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepato-protective role of indigenous drug Liv-52 in lepromatous leprosy.
    Nigam P; Dayal SG; Mukhija RD; Goyal BM; Joshi LD
    Hansenol Int; 1982 Jun; 7(1):36-44. PubMed ID: 6764921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thalidomide in the treatment of leprosy reactions. 3 years of experience in Mexico].
    Latapí F; Saúl A; Gómez-Vidal M
    Gac Med Mex; 1969 Oct; 99(10):917-31. PubMed ID: 5363611
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials.
    Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):319-27. PubMed ID: 14750577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of Hansen's disease with delayed-action sulfamides].
    Languillon J
    Dermatol Int; 1968; 7(2):84-9. PubMed ID: 5741774
    [No Abstract]   [Full Text] [Related]  

  • 36. Dapsone haemolysis in leprosy. A preliminary report.
    Menezes S; Rege VL; Sehgal VN
    Lepr India; 1981 Jan; 53(1):63-9. PubMed ID: 7218764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of leprosy with Lampren (B.663 Geigy).
    De las Aguas JT
    Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089
    [No Abstract]   [Full Text] [Related]  

  • 38. Piretanide: effective diuretic in renal failure.
    George CR
    Med J Aust; 1981 Jan; 1(2):83-4. PubMed ID: 7015088
    [No Abstract]   [Full Text] [Related]  

  • 39. Incidence of anemia in leprosy patients treated with dapsone.
    Puavilai S; Chutha S; Polnikorn N; Timpatanapong P; Tasanapradit P; Charuwichitratana S; Boonthanom A; Wongwaisayawan H
    J Med Assoc Thai; 1984 Jul; 67(7):404-7. PubMed ID: 6512448
    [No Abstract]   [Full Text] [Related]  

  • 40. [Symptomatic treatment of the leprotic reaction with hydroxychloroquine sulfate].
    Proença N
    Rev Bras Leprol; 1965; 33(1):35-44. PubMed ID: 5873236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.